C12N 15/869
Herpesviral vectors
C12N15/869 (Herpesviral vectors) appears on 46 US grants and 65 published applications in this corpus.
Search patents in C12N- Granted patents
- 46
- Published applications
- 65
- Assignees
- 32
- Inventors
- 88
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 2 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 1 | 0 |
| 2007 | 1 | 2 |
| 2008 | 0 | 1 |
| 2009 | 1 | 3 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 1 | 3 |
| 2013 | 0 | 4 |
| 2014 | 2 | 3 |
| 2015 | 5 | 3 |
| 2016 | 2 | 2 |
| 2017 | 2 | 6 |
| 2018 | 3 | 6 |
| 2019 | 5 | 5 |
| 2020 | 3 | 6 |
| 2021 | 3 | 5 |
| 2022 | 7 | 4 |
| 2023 | 1 | 3 |
| 2024 | 4 | 1 |
| 2025 | 3 | 3 |
| 2026 | 2 | 2 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compositions and methods for the treatment of skin diseases16 Jun 2026US 12,655,447 B2Krystal Biotech, Inc.
- CA2-IL15 fusion proteins for tunable regulation2 Jun 2026US 12,642,792 B2Obsidian Therapeutics, Inc.
- Syncytial oncolytic herpes simplex mutants as potent cancer therapeutics25 Nov 2025US 12,480,097 B2Research Institute At Nationwide Children's Hospital
- Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof12 Aug 2025US 12,385,068 B2Boehringer Ingelheim Animal Health USA Inc.
- Recombinant non-pathogenic Marek's disease virus constructs encoding multiple heterologous antigens4 Mar 2025US 12,239,704 B2Intervet Inc.
- Hsv gene expression vector and bxb1 integrase-mediated recombination system for high-throughput cloning27 Aug 2026US 2026/0250643 A1Albert Einstein College of Medicine
- Adeno-Associated Virus Production Platform9 Jul 2026US 2026/0193676 A1MedImmune, LLC
- Recombinant hvt vectors expressing multiple antigens of avian pathogens and uses thereof30 Oct 2025US 2025/0333766 A1Boehringer Ingelheim Animal Health USA Inc.
- Compositions and Methods for the Treatment of Congenital Ichthyoses4 Sep 2025US 2025/0277237 A1Krystal Biotech, Inc.
- Oncolytic herpes simplex virus vectors expressing immune system-stimulatory molecules31 Jul 2025US 2025/0243252 A1Virogin Biotech Canada Ltd
Most cited
By later US patents
- Virus strains63US 7,537,924 B2Biovex Limited · 2009
- Herpes virus strains for gene therapy40US 7,223,593 B2Biovex Limited · 2007
- Virus strains34US 7,063,835 B2Biovex Limited · 2006
- Recombinant HCMV and RHCMV vectors and uses thereof20US 9,249,427 B2Oregon Health & Science University · 2016
- Herpes virus strains for gene therapy19US 8,277,818 B2Biovex Limited · 2012